Moderna CEO Stéphane Bancel said on Tuesday he expects to be able to submit clinical data from COVID-19 vaccine trials on six to 11-year-olds to Health Canada in early fall, with data on the under six age group coming by the end of the year, or early in 2022.
COVID-19
Moderna CEO says clinical data from COVID-19 vaccine trials on 6 to 11 year-olds coming in the fall
More Videos
-
Health Matters: China froze COVID-19 origin tracing, AP investigation finds
-
Scottish researchers ‘chewing’ their way toward solution in global plastics pollution issue
-
Canadian businesses worried as CEBA repayment deadline looms
-
Health Matters: Yale Public Health researchers recommend annual COVID-19 vaccination
-
Health Matters: Life expectancy has dropped 1.6 years, analysis finds
-
Canadian Covid Society formed
You are viewing an Accelerated Mobile Webpage.
View Original Article